Regulated and multiple miRNA and siRNA delivery into primary cells by a lentiviral platform.
about
Targeting regulatory T cells in cancerCurrent prospects for RNA interference-based therapiesImproved knockdown from artificial microRNAs in an enhanced miR-155 backbone: a designer's guide to potent multi-target RNAiPreclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing.Gamma-retroviral vector design for the co-expression of artificial microRNAs and therapeutic proteins.Exploiting microRNA regulation for genetic engineering.Gene therapy of chronic granulomatous disease: the engraftment dilemmaFrom IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation.Kinetic analysis reveals the fate of a microRNA following target regulation in mammalian cellsRegulation of RAB5C is important for the growth inhibitory effects of MiR-509 in human precursor-B acute lymphoblastic leukemia.Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis.Artificial MiRNA Knockdown of Platelet Glycoprotein lbα: A Tool for Platelet Gene Silencing.Functional Studies of microRNAs in Neural Stem Cells: Problems and PerspectivesA diphtheria toxin resistance marker for in vitro and in vivo selection of stably transduced human cellsIncreased locomotor activity and non-selective attention and impaired learning ability in SD rats after lentiviral vector-mediated RNA interference of Homer 1a in the brainmiRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F InductionLeukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosisTIE2-expressing monocytes/macrophages regulate revascularization of the ischemic limbBicistronic gene transfer tools for delivery of miRNAs and protein coding sequences.MiRNAs confer phenotypic robustness to gene networks by suppressing biological noise.Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype.Sox2 suppression by miR-21 governs human mesenchymal stem cell properties.Transfer and Expression of Small Interfering RNAs in Mammalian Cells Using Lentiviral VectorsThe role of FOXP3 in regulating immune responses.Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines.Measurement of lentiviral vector titre and copy number by cross-species duplex quantitative PCR.A Lentiviral Fluorescent Genetic Barcoding System for Flow Cytometry-Based Multiplex Tracking.Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia.A double-switch vector system positively regulates transgene expression by endogenous microRNA expression (miR-ON vector).CD4⁺ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer.Development of hybrid baculovirus vectors for artificial MicroRNA delivery and prolonged gene suppression.Apolipoprotein B knockdown by AAV-delivered shRNA lowers plasma cholesterol in mice.Sustained inhibition of hepatitis B virus replication in vivo using RNAi-activating lentiviruses.Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome.miR-135a Inhibits Cancer Stem Cell-Driven Medulloblastoma Development by Directly Repressing Arhgef6 Expression.Engineered Tolerance: Tailoring Development, Function, and Antigen-Specificity of Regulatory T Cells.Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy.Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside.
P2860
Q27022348-C1DF006C-8F68-47E4-AC56-86A440672893Q28235733-A8FC7B65-2DA3-433E-990F-23B420CC4D38Q30388048-1DC730FA-15F6-4A69-863E-5C6AA92C5779Q33752590-F4C4AF5A-A8E0-4F9C-A8A0-AE9F951835CCQ34171679-785178F0-BB53-4502-9B4A-C7F95EEA5889Q34302499-B5EF95C6-71F0-41C9-A8BC-FEF95C8CE942Q34473374-C4D83C6F-37EE-4745-9AF9-D68F7ACD0269Q34515848-B8803288-221C-48A5-BABA-FF5BBD31FF78Q34935342-8104E7B3-580F-49D8-9707-668419FC9E76Q35391479-CA0F9787-A0E5-4575-AB83-27C751D2B518Q35591371-AED7A6B3-73B6-4733-9242-E4C1163800E3Q35692158-7DB22E4E-9641-4ED2-99AA-3E757BC0654BQ35740397-BAF35882-2CAF-45C2-91C7-5D9C8E5548B9Q36106540-C5A1A5B0-7802-4B1A-887D-A973D08E4F8CQ36501535-B96446AD-9BB8-4C63-BB58-FAA835097B59Q36757075-DF7D2AD0-EFB3-4C07-A4F0-D94ECB8028DCQ37012644-826F45A8-104B-47FF-91F8-82D955E5FF08Q37188563-0EB8C375-26E2-448B-B93B-BF672C0DAA34Q37225120-DE7B6050-061F-4DE1-9F67-41D03B5214CDQ37331613-928216EA-4DD9-4153-88EB-019972D98B62Q37395719-2B4BB84B-DA19-494B-9B4B-738E0050489DQ37516478-CBE5B88D-B114-4850-9EDC-6CD44209976CQ38118762-2C7E64EC-A848-425B-87E6-A34EB75D0DB3Q38129079-C2D0F598-D58C-484B-84A4-50FD078C6FA4Q38154151-D4AB6DAE-6F4D-4B18-8EC8-158FA2D23A02Q38850346-D9D5440B-CCF9-4C70-A83F-810BB9840BBDQ38933106-45F9B764-5020-4900-A3B7-E246BA904825Q39181050-28BE6476-791A-4F17-BC28-26A11E1F9037Q39188886-087FCF97-5B43-418F-AB87-DD84F6931DC7Q39295075-E584C028-37F4-4B61-BDBD-613CB6082D47Q39512175-21B17122-5885-4D1B-AC02-5037914F746BQ39595680-337A85B8-FDE1-4E63-B978-C52F9846FB3FQ41691498-96B6EB2C-3B71-4C95-9110-C10570705908Q42745318-3BD0D9F8-3906-4050-BAD8-1776E98D09A7Q45872619-6EAF8CB5-CD32-4020-B623-A472A8314594Q47150746-14C56C60-EB5F-420B-B123-F093F7AE2948Q47571295-BD63C4EA-59EC-454D-813A-B5709CC4F308Q52655307-1E0F98ED-E6C1-4AB1-B632-17D761DF2759Q52674851-DF7E5486-7C9C-4DD4-A4A9-418E1936F94C
P2860
Regulated and multiple miRNA and siRNA delivery into primary cells by a lentiviral platform.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Regulated and multiple miRNA a ...... ells by a lentiviral platform.
@en
Regulated and multiple miRNA a ...... ells by a lentiviral platform.
@nl
type
label
Regulated and multiple miRNA a ...... ells by a lentiviral platform.
@en
Regulated and multiple miRNA a ...... ells by a lentiviral platform.
@nl
prefLabel
Regulated and multiple miRNA a ...... ells by a lentiviral platform.
@en
Regulated and multiple miRNA a ...... ells by a lentiviral platform.
@nl
P2860
P50
P356
P1433
P1476
Regulated and multiple miRNA a ...... ells by a lentiviral platform.
@en
P2093
Ferdinando Pucci
Rosa Bacchetta
P2860
P304
P356
10.1038/MT.2009.48
P577
2009-03-17T00:00:00Z